Home688266 • SHA
add
Suzhou Zelgen Biopharmaceuticals Co Ltd
Previous close
ÂĄ80.06
Day range
ÂĄ75.52 - ÂĄ80.73
Year range
ÂĄ75.52 - ÂĄ134.17
Market cap
21.74B CNY
Avg Volume
110.48K
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 219.29M | 47.34% |
Operating expense | — | — |
Net income | -67.28M | -68.51% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -35.68M | 45.67% |
Effective tax rate | 4.39% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 253.04M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -5.10% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -67.28M | -68.51% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Mar 18, 2009
Website
Employees
910